Veradigm (NASDAQ:MDRX – Get Free Report) and Doximity (NYSE:DOCS – Get Free Report) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, earnings, valuation, risk and dividends.
Earnings & Valuation
This table compares Veradigm and Doximity”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Veradigm | $1.53 billion | 0.38 | N/A | N/A | N/A |
| Doximity | $644.86 million | 5.98 | $196.05 million | $0.99 | 21.32 |
Analyst Recommendations
This is a breakdown of recent ratings and target prices for Veradigm and Doximity, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Veradigm | 0 | 0 | 0 | 0 | 0.00 |
| Doximity | 3 | 13 | 6 | 2 | 2.29 |
Doximity has a consensus target price of $29.33, indicating a potential upside of 38.99%. Given Doximity’s stronger consensus rating and higher probable upside, analysts plainly believe Doximity is more favorable than Veradigm.
Institutional and Insider Ownership
87.2% of Doximity shares are owned by institutional investors. 2.3% of Veradigm shares are owned by insiders. Comparatively, 31.8% of Doximity shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Profitability
This table compares Veradigm and Doximity’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Veradigm | N/A | N/A | N/A |
| Doximity | 30.40% | 20.40% | 17.43% |
Risk & Volatility
Veradigm has a beta of 0.53, indicating that its share price is 47% less volatile than the S&P 500. Comparatively, Doximity has a beta of 1.29, indicating that its share price is 29% more volatile than the S&P 500.
Summary
Doximity beats Veradigm on 11 of the 13 factors compared between the two stocks.
About Veradigm
Veradigm Inc., a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions. The company operates through two segments, Hospitals and Large Physician Practices, and Veradigm. The Hospitals and Large Physician Practices segment provides integrated clinical and financial management solutions, which primarily include EHR-related software; and related installation, support and maintenance, outsourcing, private cloud hosting, and revenue cycle management services. The Veradigm segment offers payer and life sciences solutions, which are primarily targeted at payers, life sciences companies, and other healthcare stakeholders; and software applications for patient engagement and EHR software to single-specialty, and small and mid-sized physician practices, including related clinical, financial, administrative, and operational solutions. Its solutions enable clients to transition, analyze, and coordinate care, and enhance the healthcare delivery across the care community. The company serves physicians, hospitals, governments and militaries, health systems, health plans, life-sciences companies, retail clinics, surgery centers, retail pharmacies, pharmacy benefit managers, insurance companies, employer wellness clinics, consumers, lab companies, urgent care facilities, and venture capital firms, as well as post-acute organizations, such as home health and hospice agencies. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.
About Doximity
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company’s cloud-based platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical companies and health systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
